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Bacterial persister cells are dormant and highly tolerant to lethal antibiotics, which are
believed to be the major cause of recurring and chronic infections. Activation of toxins
of bacterial toxin-antitoxin systems inhibits bacterial growth and plays an important
role in persister formation. However, little is known about the overall gene expression
profile upon toxin activation. More importantly, how the dormant bacterial persisters
evade host immune clearance remains poorly understood. Here we demonstrate
that a Pseudomonas aeruginosa toxin-antitoxin system HigB-HigA is required for the
ciprofloxacin induced persister formation. Transcriptome analysis of a higA::Tn mutant
revealed up regulation of type III secretion systems (T3SS) genes. Overexpression of
HigB increased the expression of T3SS genes as well as bacterial cytotoxicity. We further
demonstrate that wild type bacteria that survived ciprofloxacin treatment contain higher
levels of T3SS proteins and display increased cytotoxicity to macrophage compared to
vegetative bacterial cells. These results suggest that P. aeruginosa accumulates T3SS
proteins during persister formation, which can protect the persister cells from host
clearance by efficiently killing host immune cells.
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INTRODUCTION
Bacterial persisters are rare cells in a bacterial population that are tolerant to lethal antibiotics.
Formation of persisters has been observed in almost all bacterial species investigated (Lewis, 2010).
Persistence as a phenotypic switch is pre-existing in bacterial populations, with the characteristic of
dormancy or slow growth. Reinoculation of the persister cells results in a similar heterogeneous
population in which a subpopulation is tolerant to antibiotics. Formation of persister cells is
influenced by environmental stresses and growth phases (Balaban et al., 2004; Keren et al., 2004;
Dörr et al., 2009, 2010; Bernier et al., 2013; Helaine et al., 2014).
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Toxin–antitoxin (TA) systems, composed of a toxin and a
cognate antitoxin, play important roles in persister formation
(Kim et al., 2011; Germain et al., 2013; Maisonneuve et al.,
2013; Helaine et al., 2014; Verstraeten et al., 2015). Toxins can
inhibit bacterial protein synthesis, DNA replication, cell wall
synthesis or depolarize membrane, resulting in slow growth or
dormant persister cells (Page and Peti, 2016). Toxins can be
activated by various stimulations. For example, environmental
stresses, such as starvation, induce the synthesis of bacterial
alarmones guanosine tetraphosphate (ppGpp) and guanosine
pentaphosphate (pppGpp), which trigger the degradation of
antitoxins by proteases, resulting in activation of toxins
(Nguyen et al., 2011; Maisonneuve et al., 2013). In addition,
fluoroquinolones and oxidative stresses can activate toxins and
induce persister formation through SOS response (Dörr et al.,
2009, 2010; Wu et al., 2012).
Bacterial persisters are believed to be responsible for recurrent
and chronic infections, due to the failure of antibiotics to
eradicate the bacterial pathogens (Lewis, 2007). However, the
mechanism by which the rare dormant persister cells evade
the killing by host phagocytes remains poorly understood.
Although it is believed that persister cells embedded in biofilm
are shielded from host phagocytes (Leid, 2009), whether free
persister cells are capable of surviving the attack of immune
cells is not known. Numerous studies have revealed roles of TA
systems in the regulation of bacterial gene expression, including
virulence factors (Bertram and Schuster, 2014; Wen et al., 2014).
Therefore, studies on the functions of TA systems will facilitate
the understanding of the physiology of persister cells as well as
their survival strategies within the host environments.
Pseudomonas aeruginosa is an opportunistic pathogen that
causes acute and chronic infections in human (Balasubramanian
et al., 2013). In P. aeruginosa strain PA14, two potential toxin-
antitixoin systems have been identified, namely RelE-RelB and
HigB-HigA (Williams et al., 2011; Wood and Wood, 2016). It
has been demonstrated that HigB is a RNase, which cleaves
mRNAs (Hurley and Woychik, 2009; Schureck et al., 2015,
2016a,b; Wood and Wood, 2016). In this study, we demonstrate
that the toxin HigB contributes to persister formation. RNA-seq
results revealed up regulation of type III secretion system (T3SS)
genes in a higA::Tn mutant. The T3SS is a needle-like apparatus
conserved in Gram negative pathogenic bacteria, through which
effector proteins are directly translocated into the host cells,
altering cell signaling or causing cell death. In P. aeruginosa,
the T3SS plays an essential role in bacterial pathogenesis by
killing phagocytes (Hauser, 2009; Diaz and Hauser, 2010).
Consistent with the T3SS gene expression pattern, the higA::Tn
mutant displayed higher cytotoxicity than the wild type strain.
As expected, overexpression of the HigB resulted in a similar
phenotype. These results imply a high level of cytotoxicity of
the persister cells. Indeed, compared to vegetative cells, cells that
survived short term ciprofloxacin treatment displayed increased
cytotoxicity, which depends on HigB mediated up regulation of
the T3SS. To our knowledge, this is the first demonstration of a
connection between the HigB-HigA system and the T3SS. Our
results suggest that T3SS proteins get accumulated during the
process of persister formation, enabling the bacterial persisters
to survive host clearance by actively killing the host immune
cells.
RESULTS
HigA Negatively Regulates the higB-higA
Operon
A recent study identified the open reading frame of HigB in
PA14 and demonstrated its growth inhibitory function (Wood
andWood, 2016). Inmost type II TA systems, toxin and antitoxin
genes form one operon and the antitoxin binds to and represses
its own promoter (Wood and Wood, 2016). To test whether
higB and higA are in the same operon, we designed a pair of
primers annealing to the 5′ end of higB and 3′ end of higA
coding region, respectively (Figure 1A), and performed RT-PCR.
Total RNA was isolated from PA14 and a higA mutant from
the PA14 transponson insertion mutant library (Liberati et al.,
2006). A 384-bp PCR product was amplified using cDNA from
the higA::Tn mutant (Figure 1B, lane 4), and the size was the
same as that when genomic DNA was used as the template
(Figure 1B, lane 2). Substantially less PCR product was obtained
when cDNA from wild type PA14 was used as the template
(Figure 1B, lane 3), suggesting a lower HigB mRNA level. To
confirm the transcriptional level of higB and higA, we performed
quantitative RT PCR with previously reported PA1769 and proC
as internal controls for normalization (Savli et al., 2003; Son et al.,
2007). Since HigB might cleave mRNAs and affect the expression
of multiple genes, we included the 16S rRNA (PA0668.1) (Ruzin
et al., 2007), which might not be a target of HigB, as another
internal control. Similar mRNA fold of changes (within 1.5-fold
difference) were observed when proC and the 16S rRNA were
used as internal controls. Therefore, we used the 16S rRNA as the
internal control in this study. At both exponential and stationary
growth phases, the mRNA levels of higB and higA in the higA::Tn
mutant were higher than those in wild type PA14 (Figures 1C,D).
In addition, a previous microarray analysis has demonstrated an
up regulation of higB in a higAmutant (Wood and Wood, 2016).
In combination, these results suggest that higB and higA are in
the same operon, which is negatively regulated by the HigA.
To examine whether HigA binds to the promoter of its own
operon, we first determined the transcriptional start site by a 5′
RACE analysis. The start site was located at 29 bp upstream of the
start codon for higB (Figure 1E). Of note, we found a palindromic
sequence downstream of the −10 region (Figure 1E), which
might be the binding site of HigA. Electrophoretic mobility shift
assay (EMSA) revealed an interaction between the fragment and
HigA, and mutation of the palindromic sequence abolished the
interaction (Figure 1F). These results suggest that HigA directly
binds to and represses the promoter of the higB-higA operon.
The Lon Protease Contributes to the
Degradation of HigA
To identify which protease is involved in the degradation of
HigA, a C-terminus His-tagged HigA (HigA-His) driven by a
tac promoter was introduced into wild type PA14. After 60min
of culture in the presence of IPTG, spectinomycin was added
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FIGURE 1 | HigA negatively regulates the higB-higA operon. (A) Sketch map of the higB-higA operon. Arrows indicate the directions and locations of the
primers for RT-PCR. (B) Total RNA was isolated from PA14 and the higA::Tn mutant. cDNA was synthesized and used as templates in PCR. RNAs were used in
RT-PCR as negative controls. (C,D) The relative mRNA levels of higB and higA genes in PA14 and the higA::Tn mutant. Total RNA was isolated and the mRNA levels
were determined by quantitative RT-PCR with the 16S rRNA as the internal control. Data represents the mean ± standard deviation from three independent
(Continued)
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FIGURE 1 | Continued
experiments performed in triplicate. *p < 0.05; **p < 0.01 compared to wild type PA14 by Student’s t-test. (E) Promoter region of the higB-higA operon. The
predicted −10 and −35 elements of the promoter are boxed. The transcriptional start site is indicated by a black arrow, and the start codon of higB is underlined. The
palindromic sequences of hypothetical HigA binding sites are indicated by gray arrows. (F) EMSA displaying binding of HigA to the higB-higA promoter. Purified
HigA-His protein was incubated with the 38-bp DNA fragment indicated by the box with dashed lines in (E) or altered sequence. The mixtures were electrophoresed
and observed by ethidium bromide staining. (G) Cleavage of HigA by the Lon protease. Wild type PA14, the clpP::Tn and lon::Tn mutants carrying
pMMB67EH-higA-His were cultured in the presence of 1mM IPTG for 1 h. Then 50µg/ml spectinomycin was added to the medium. At indicated time points, the
HigA-His levels were determined by Western blot analysis with an anti-His antibody. The relative density of each band was determined with Image J.
to block protein synthesis, then the stability of HigA-His was
monitored. In wild type PA14 and a clpP::Tn mutant, the HigA-
His was gradually degraded. However, the protein was stable in a
lon::Tn mutant (Figure 1G, Figure S1A), suggesting a role of the
Lon protease in the degradation of HigA.
HigB-HigA Regulates Persister Formation
in PA14
To test the role of HigB-HigA in persister formation, the
higA::Tn mutant was examined for a time-dependent killing by
ciprofloxacin. Compared to the wild type PA14, the higA::Tn
mutant displayed 100-fold higher survival rate, which was
restored to the wild type level by complementation with an intact
higA gene (Figure 2A). However, a 1higB mutant displayed a
similar survival rate as the wild type PA14 (Figure 2B), which we
suspect might be due to redundant TA systems in P. aeruginosa.
It has been demonstrated that sublethal level of ciprofloxacin
induces persister formation (Dörr et al., 2009, 2010). Thus, we
examined the role of HigB in ciprofloxacin induced persister
formation as previously described (Dörr et al., 2009, 2010).
Pre-exposure to 0.025µg/ml (1/10 MIC) ciprofloxacin increased
the survival rate of wild type PA14 by approximately 5-fold,
suggesting an induction of persister formation (Figure 2B).
However, deletion of higB or the higB-higA operon abolished
such induction (Figure 2B). The expression of higB and higA
was induced by the ciprofloxacin treatment (Figures 2C,D) and
overexpression of HigB increased bacterial survival rate by
approximately 1000-fold (Figure 2E). In addition, the minimal
inhibitory concentration (MIC) of ciprofloxacin was not altered
by the mutation of higA or overexpression of higB (data not
shown). In combination, these results demonstrate that HigB
contributes to persister formation.
Transcriptome Analysis of the higA::Tn
Mutant
RNA-seq analyses were employed to explore the effect of
higA inactivation on bacterial global gene expression at both
exponential and stationary growth phases. Compared to wild
type PA14, expression of 193 genes was altered in the higAmutant
at both growth phases (Table S1). Of note, all of the T3SS genes
were up regulated in the higA mutant (Table 1), suggesting a
regulatory role of the TA system on the T3SS.
Increased Expression of T3SS Genes and
Cytotoxicity of the higA::Tn Mutant
To confirm the elevated expression of T3SS genes in the higA::Tn
mutant, the mRNA levels of exsA, exsC (two positive regulatory
genes), pcrV (required for translocation of effector proteins) and
exoU (encodes for an effector protein) were examined. Mutation
of higA resulted in highermRNA levels of all of these genes, which
were restored to the wild type levels by complementation with a
higA gene (Figure 3A, Figure S1B). As the higA::Tn mutant grew
slower than the wild type strain, translation of the T3SS genes
might be impeded. To test this possibility, we examined PcrV
protein levels by immunostaining in strains harboring a mcherry
gene driven by the promoter of higB-higA (PhigB-mcherry).
Compared to the wild type strain, the higA::Tn mutant expressed
higher levels of PcrV and mCherry proteins (Figure S1C). Next,
we constructed a C-terminal His-tagged ExoU driven by its
native promoter (PexoU-ExoU-His). Consistent with the above
results, the levels of ExoU-His protein in the higA::Tn mutant
were higher at both exponential (Figure 3B) and stationary
growth phases (Figure S1D).
To test whether the increased expression of T3SS genes
leads to higher cytotoxicity, we performed LDH release assay.
Compared to wild type PA14, the higA::Tn mutant caused
quicker cell death to either macrophages (Raw264.7) (Figure 3C)
or epithelial cells (HeLa) (Figure S1E). In addition, when
HeLa cells were infected with strains containing the ExoU-
His, more ExoU was translocated into the cells by the higA::Tn
mutant (Figures S1F,G). Altogether, these results demonstrate
that mutation of the higA results in up regulation of T3SS genes
and consequently higher cytotoxicity.
Activation of HigB Increases the
Expression of T3SS Genes and Cytotoxicity
HigB functions as a RNase, which is directly inhibited by HigA
(Wood and Wood, 2016). Thus, we examined the role of
HigB in the expression of T3SS genes and cytotoxicity. First, a
1higB1higA double mutant was constructed, which displayed
similar levels of T3SS gene expression and cytotoxicity as the
wild type PA14 (Figures S2A,B). Second, a C-terminal His-
tagged HigB driven by a regulatable tac promoter (Ptac-higB-
His) or the empty vector was introduced into wild type PA14
(Figure S2C). Addition of IPTG increased the mRNA levels of
exsC, exsA, pcrV, and exoU, with the highest levels in the presence
of 0.5mM IPTG. In the presence of 1.0mM IPTG, the mRNA
levels of those genes were reduced, which might be due to strong
growth inhibition as a consequence of high level expression of the
HigB (Figures 4A–D). To further confirm the expression level of
ExoU, we transferred the plasmid carrying PexoU-ExoU-His into
the above strains. Consistently, the protein level of ExoU was
increased by the overexpression of HigB (Figure 4E).
Next, we determined the correlation between bacterial
cytotoxicity and expression levels of HigB. Bacteria grown in
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FIGURE 2 | Role of HigA-HigB in persister formation. (A) Wild type PA14, a higA::Tn mutant and a complemented strain were treated with 0.25µg/ml
ciprofloxacin. At indicated time points the survival rates were determined by plating assay. (B) Wild type PA14, the 1higA and 1higA1higB mutants were cultured in
the presence or absence of 0.025µg/ml ciprofloxacin for 2 h and then treated with 0.25µg/ml ciprofloxacin. The survival rates were determined by plating assay.
(C,D) Wild type PA14 was treated with 0.025µg/ml ciprofloxacin for 2 h and the mRNA levels of higB or higA were determined by quantitative RT-PCR. Error bars
represent the standard error. *p < 0.05, by Student’s t-test. (E)Wild type PA14 carrying a Ptac driven higB gene or the empty vector were cultured with 1mM IPTG for
2 h, followed by treatment with 0.25µg/ml ciprofloxacin. The survival rates were determined by plating. Error bars represent the standard errors. The graphs are
representatives of three independent experiments.
the presence 0.1 mM IPTG displayed the highest cytotoxicity
to both Raw264.7 (Figure 4F) and HeLa cells (Figure S2D).
However, further increase of the IPTG concentration reduced
the cytotoxicity (Figure 4F, Figure S2D), although the mRNA
levels of the T3SS genes were higher than or similar to those in
the presence 0.1 mM IPTG (Figures 4A–D). Mutation of exsA
severely reduced the HigB mediated increase of the T3SS gene
expression and cytotoxicity (Figures 4A–F, Figure S2D). These
results suggest that HigB promotes bacterial cytotoxicity through
the T3SS. However, too high level of HigB might repress the
overall bacterial fitness, which impedes the translocation of T3SS
effector proteins.
Cytotoxicity of Persister Cells
Our results from the higA::Tn mutant and the HigB
overexpressing strain demonstrate that activation of HigB
increases persister formation and T3SS mediated cytotoxicity.
A more important question is whether persister cells harbor
higher levels of T3SS proteins and are more cytotoxic than their
isogenic vegetative cells.
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TABLE 1 | mRNA levels of T3SS genes in the higA::Tn mutant compared to those in wild type PA14.
Locus Tag PA14 Locus Tag
PAO1





PA14_RS17315 PA1690 pscU Translocation protein in type III secretion 5.040 5.03E-18 3.733 1.51E-12
PA14_RS17310 PA1691 pscT Translocation protein in type III secretion 6.569 5.63E-16 3.901 2.57E-08
PA14_RS17305 PA1692 Probable translocation protein in type III
secretion
4.022 3.45E-05 5.280 4.73E-06
PA14_RS17300 PA1693 pscR Translocation protein in type III secretion 4.259 2.16E-13 4.456 6.79E-11
PA14_RS17295 PA1694 pscQ Translocation protein in type III secretion 4.940 9.64E-21 5.341 1.30E-21
PA14_RS17285 PA1696 pscO Translocation protein in type III secretion 6.773 4.84E-13 7.603 1.83E-16
PA14_RS17275 PA1698 popN Type III secretion outer membrane protein
PopN precursor
9.668 1.99E-17 10.303 2.25E-19
PA14_RS17270 PA1699 Pcr1 7.646 6.87E-22 10.891 3.05E-29
PA14_RS17265 PA1700 Pcr2 9.520 3.65E-12 8.711 1.06E-11
PA14_RS17260 PA1701 Pcr3 15.069 3.35E-26 4.898 6.08E-11
PA14_RS17255 PA1702 Pcr4 7.637 1.40E-07 3.461 5.32E-03
PA14_RS17250 PA1703 pcrD Type III secretory apparatus protein PcrD 8.296 2.55E-36 4.419 8.01E-21
PA14_RS17245 PA1704 pcrR Transcriptional regulator protein PcrR 10.180 1.10E-07 3.673 1.04E-03
PA14_RS17190 PA1715 pscB Type III export apparatus protein 10.823 2.91E-27 7.750 1.25E-22
PA14_RS17185 PA1716 pscC Type III secretion outer membrane protein PscC
precursor
7.545 8.13E-34 5.668 5.06E-26
PA14_RS17180 PA1717 pscD Type III export protein PscD 8.176 8.09E-17 6.118 5.71E-14
PA14_RS17175 PA1718 pscE Type III export protein PscE 3.671 3.44E-10 5.666 1.50E-18
PA14_RS17170 PA1719 pscF Type III export protein PscF 3.486 4.18E-07 6.825 4.20E-14
PA14_RS17165 PA1720 pscG Type III export protein PscG 4.787 3.27E-17 6.694 4.94E-24
PA14_RS17160 PA1721 pscH Type III export protein PscH 5.776 2.08E-19 5.984 2.64E-19
PA14_RS17155 PA1722 pscI Type III export protein PscI 5.717 5.44E-22 4.898 2.78E-19
PA14_RS17150 PA1723 pscJ Type III export protein PscJ 6.078 7.63E-27 5.100 1.98E-22
PA14_RS17145 PA1724 pscK Type III export protein PscK 10.686 3.18E-32 5.262 2.00E-14
PA14_RS17140 PA1725 pscL Type III export protein PscL 7.367 4.46E-30 5.816 2.25E-22
PA14_RS17240 PA1705 pcrG Regulator in type III secretion 10.210 4.38E-09 7.620 4.03E-08
PA14_RS17235 PA1706 pcrV Type III secretion protein PcrV 6.118 4.35E-30 9.030 5.90E-44
PA14_RS17230 PA1707 pcrH Regulatory protein PcrH 6.341 9.18E-29 19.662 1.89E-73
PA14_RS17225 PA1708 popB Translocator protein PopB 5.914 1.39E-21 10.593 1.10E-37
PA14_RS17220 PA1709 popD Translocator outer membrane protein PopD
precursor
4.516 3.14E-12 6.590 5.54E-20
PA14_RS17215 PA1710 exsC ExsC, exoenzyme S synthesis protein C
precursor.
4.807 1.56E-23 6.655 3.21E-34
PA14_RS17210 PA1711 ExsE 4.700 2.32E-05 5.277 1.48E-06
PA14_RS17205 PA1712 exsB Exoenzyme S synthesis protein B 5.985 1.56E-21 5.144 5.97E-22
PA14_RS17200 PA1713 exsA Transcriptional regulator ExsA 5.374 4.24E-24 4.824 4.09E-22
PA14_RS17195 PA1714 ExsD 6.886 2.26E-16 9.658 9.68E-24
PA14_RS00230 PA0044 exoT Exoenzyme T 6.141 4.01E-28 8.190 3.39E-41
PA14_RS14785 PA2191 exoY Adenylate cyclase ExoY 6.589 1.35E-30 6.053 1.75E-31
PA14_RS20960 exoU ExoU 4.443 1.56E-21 8.603 1.97E-44
PA14_RS20955 spcU SpcU 3.093 9.69E-10 4.960 1.31E-20
PA14_RS05730 PA3842 spcS SpcS 6.434 1.11E-08 11.384 4.76E-15
E, exponential growth phase.
S, stationary growth phase.
In the bacterial survival assay, we noticed lysis of bacterial cells
during ciprofloxacin treatment, presumably due to production
and release of pyocins (Penterman et al., 2014; Sun et al., 2014).
Based on this phenotype, we developed a method to collect
persister cell by washing the ciprofloxacin treated bacteria with
0.3M sucrose, which could efficiently remove lysed cell debris.
To assess the effectiveness of this method, we treated a wild
type PA14 strain containing a gfp gene driven by the higB
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FIGURE 3 | Expression levels of T3SS genes in wild type PA14, the higA::Tn mutant and complemented strain. (A) Relative mRNA levels of exsC, exsA,
pcrV, and exoU in indicated strains at exponential growth phase (OD600 = 0.8∼1.0). Error bars represent the standard errors. *p < 0.05, **p < 0.01, ***p < 0.005
compared to wild type PA14 by Student’s t-test. (B) Bacteria carrying an exoU-His driven by its native promoter (PexoU-exoU-His) were grown in LB at 37
◦C. At the
OD600 of 1.0, bacteria were collected. Samples from equivalent bacterial cells were loaded into SDS-PAGE gels and stained with Coomassie blue or probed with an
anti-His antibody. (C) Raw264.7 cell were infected by indicated strains at an MOI of 10. At indicated time points, the relative cytotoxicity was determined by the LDH
release assay.
promoter (PhigB-gfp) with 0.025 µg/ml ciprofloxin for 2 h to
induce persister formation. Then the cells were incubated with
0.25 µg/ml ciprofloxacin for 6 h, resulting in a survival rate of
0.01% as determined by plating assay. Such treated bacterial
cells were harvested by centrifugation and washed twice with
0.3M sucrose, followed by propidium iodide (PI) staining. As
presented in Figure S3A, 93 ± 0.5% collected cells were PI
negative, suggesting an effective isolation of persister cells. In
addition, bacteria with strong green fluorescence were negative
for PI staining, or vice versa (Figure S3A), indicating an up
regulation of HigB in the persister cells. To examine the levels
of PcrV in the persister cells, the collected bacterial cells were
subjected to immunostaining with an anti-PcrV antibody. 79.7±
3.7% GFP positive cells were positive for PcrV (Figure S3B). In
combination, these results demonstrate elevated levels of HigB
and PcrV in persister cells.
Next, we examined the cytotoxicity of persister cells. Persister
cells of wild type PA14 were collected as aforementioned
and used to infect Raw264.7 cells. However, the persister
cells displayed minimal cytotoxicity compared to vegetative
cells (Figures S3C,D). We suspected that the 6-h exposure to
ciprofloxacin might result in highly dormant cells that are unable
to inject T3SS effectors. Therefore, we reduced the treatment
time to 30 min, which resulted in 25% bacterial survival rate.
As represented in Figure 5A, 83 ± 2.8% cells collected after
ciprofloxacin treatment were PI negative. 89 ± 6.6% cells were
GFP positive but GFP and PI double positive cell was barely
observed (Figure 5A, lower panels), suggesting high levels of
HigB in survived cells. Among the cells, 77± 10.1% were double
positive for GFP and PcrV (Figure 5B, lower panels), whereas
bacteria grown in LB were negative for GFP or PcrV (Figure 5B,
upper panels). These results suggest that the expression levels
of HigB and PcrV were higher in the survived bacterial cells
than those in vegetative cells. These surviving bacteria displayed
higher cytotoxicity to Raw264.7 cells (Figure 5C). Addition of
anti-PcrV antibody, which has been demonstrated to protect
cells from T3SS mediated cytotoxicity (Warrener et al., 2014),
protected the Raw264.7 cells from killing by the bacteria survived
of the ciprofloxacin treatment (Figure 5C).
To exclude the possibility that the macrophages were killed
from stimulation by large amount of LPS or other bacterial
ligands in the collected bacterial samples, we tested an exsA::Tn
mutant strain. After the same ciprofloxacin treatment, the
survival rate of the mutant was similar to that of wild type
PA14, however, the bacteria displayed minimum cytotoxicity
(Figures S3C,D). Next, we incubated wild type bacteria at 50◦C
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FIGURE 4 | HigB promotes T3SS mediated cytotoxicity. Wild type PA14 and an exsA::Tn mutant containing pMMB67EH-higB-His or pMMB67EH was grown in
the presence of indicated concentrations of IPTG for 3 h. Quantitative RT-PCR was used to determine the relative mRNA levels of exsC (A), exsA (B), pcrV (C), and
exoU (D). (E) PA14 or exsA::Tn containing exoU-His driven by its native promoter (PexoU-exoU-His) and pMMB67EH-higB or pMMB67EH was grown in the presence
of indicated concentrations of IPTG for 3 h. Samples from equivalent bacterial cells were loaded into SDS-PAGE gels and stained with Coomassie blue or or probed
with an anti-His antibody. The relative density of each band was determined by Image J. (F) Raw264.7 cells were infected with the bacteria at an MOI of 10 for 3.5 h,
followed by LDH release assay. ND, not detectable.
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for 30min, which also resulted in 25% survival rate. The
surviving bacteria barely caused cell death (Figures S3C,D). In
combination, the above results demonstrate that compared to
vegetative cells, bacteria that survived the 30 min ciprofloxacin
treatment contain higher level of T3SS proteins, which leads to
increased cytotoxicity.
HigB Contributes to the Increased T3SS
Gene Expression and Cytotoxicity of
Bacteria Survived Ciprofloxacin Treatment
To examine the role of HigB in the expression of T3SS genes
in bacteria survived ciprofloxacin treatment, we treated either
the 1higB mutant or the 1higB1higA mutant with 0.025 µg/ml
ciprofloxin for 2 h followed by incubation with 0.125 µg/ml
ciprofloxacin for 30min. The expression levels of HigB and
PcrV were examined by fluorescence microscopy as described
above. Similar to wild type PA14, the promoter activity of higB
was increased in the surviving bacteria (Figures S4, S5). The
stronger fluoresce in the 1higB1higA mutant further confirmed
the negative regulatory role of the HigA on the higB-higA operon
(Figures S4, S5). The levels of PcrV were significantly lower in
the 1higB or 1higB1higA mutant than that in the wild type
PA14 (Figures S4, S5). Consistently, the 1higB or 1higB1higA
mutant cells survived ciprofloxacin treatment displayed lower
cytotoxicity compared to the counterpart of wild type cells
(Figure 5D). Therefore, HigB plays an important role in the up
regulation of T3SS genes and increased cytotoxicity in survived
bacteria.
DISCUSSION
In this study, we demonstrated that HigB is involved in
ciprofloxacin induced persister formation and up regulation
of the T3SS genes in P. aeruginosa. Mutation of higA or
overexpression of higB did not alter the MIC of ciprofloxacin to
the bacteria. Our RNA-seq results demonstrated no significant
change in the expression levels of the multidrug eﬄux pumps
in the higA mutant. Quantitative RT PCR results confirmed
that the expression level of the major multidrug eﬄux pump
MexAB-OprM was not altered in the higA mutant or the higB
overexpression strain (data not shown) (Dreier and Ruggerone,
2015). However, the bacterial survival rate was significantly
increased by the mutation of higA or overexpression of higB
after ciprofloxacin treatment (Figures 2A,E), suggesting a role of
HigA-HigB in persister formation.
Through a microarray analysis, Wood et al. found that
mutation of higA reduced the expression of pyochelin
biosynthesis genes (Wood and Wood, 2016). Our RNA-seq
analysis of the higA::Tn mutant revealed similar expression
pattern of those genes (Table S1). In addition, the whole T3SS
gene clusters were up regulated, which we demonstrate to
be dependent on HigB. The P. aeruginosa In M. tuberculosis,
overexpression of HigB reduced the levels of a subset of mRNAs
and increased HigB is the cleavage of tmRNA, which is involved
in the rescue of ribosomes stalled on mRNAs (Christensen and
Gerdes, 2003; Schuessler et al., 2013). It has been demonstrated
in E. coli andM. tuberculosis that HigB associates with ribosome
and cleaves mRNA at A-rich sequences (Hurley and Woychik,
2009; Schureck et al., 2015, 2016a,b). In addition, mutation of
the higA gene did not lead to bacterial death (Wood and Wood,
2016 and our study). These results indicate that HigB might have
a specific range of target mRNAs. As many genes contain A-rich
codons, it is difficult to judge the target mRNAs solely based on
the sequence. One of the possibilities is that the recognition of
target mRNA or subsequent cutting by the HigB is affected by
the movement of ribosome, i.e., the longer the ribosome stall at
the A-rich codons, the more likely the mRNA is cleaved by HigB.
As it has been demonstrated that ribosome stalling is affected by
the amino acid sequence as well as environmental stimulations
(Jin et al., 2016; Wilson et al., 2016), it will be interesting to
examine the HigB mediated cleavage of the A-rich codons (such
as AAA) with different neighboring sequences or under different
conditions.
In this study, we used various concentrations of IPTG to
induce ectopic expression of HigB in wild type PA14. With
increasing expression of the HigB, the levels of T3SS gene
expression and bacterial cytotoxicity rose and then dropped.
Consistent with these observations, wild type PA14 that survived
0.5-h ciprofloxacin treatment displayed higher T3SS mediated
cytotoxicity. However, bacteria that survived 6-h ciprofloxacin
treatment displayed minimal cytotoxicity, although the PcrV
level was higher than that in untreated bacteria. We hypothesize
that the HigB recognizing sites might be overrepresented in the
mRNA of a T3SS negative regulator, rendering it more vulnerable
to HigB mediated cleavage. Of note, overexpression of HigB
increased the expression levels of T3SS genes in an exsA::Tn
mutant (Figures 4A–F). These results suggest that the HigB
targeted T3SS regulator might repress the expression of T3SS
genes independent of ExsA.
On the other hand, with higher levels of HigB, mRNAs with
less HigB recognizing sites are also cleaved, thus reducing the
overall biological fitness and the bacterial ability to respond to
host cell contact. In addition, the assembly of T3SS apparatus or
translocation of T3SS effectors might be impeded, thus leading
to reduced cytotoxicity. Given the complicated environment in
the host, each bacterium might encounter different levels of
antibiotics. It might be possible that during persister formation,
the levels of activated HigB are heterologous among the bacterial
population. Moderate activation of HigB increases the expression
of T3SS and bacterial cytotoxicity, while further up regulation
and activation of HigB render the bacteria dormant and highly
tolerant to antibiotics. It has been demonstrated in an animal
model that T3SS-negative bacteria are protected from host
clearance by the isogenic wild type strain, which actively kills
phagocytes through the T3SS (Hauser, 2009; Diaz and Hauser,
2010; Czechowska et al., 2014). Therefore, we suspect that
in the bacterial population that survived antibiotic treatment,
bacteria with higher cytotoxicity might protect highly dormant
cells from host immune cells, thus enable the survival of the
persister cells. In biofilm, HigB in a small portion of bacteria
might be activated, leading to persister formation as well as up
regulation of T3SS genes. We previously found that the biomass
of P. aeruginosa biofilm was reduced by ciprofloxacin treatment,
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FIGURE 5 | Levels of HigB, PcrV and cytotoxicity of bacterial cells that survived ciprofloxacin treatment. PA14/PhigB-gfp was cultured in the presence of
0.025 µg/ml ciprofloxacin for 2 h and then treated with 0.125 µg/ml ciprofloxacin for 30 min. The bacteria were washed with PBS twice, stained with PI
(Continued)
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FIGURE 5 | Continued
(A) or fixed and permeabilized and then stained with rabbit anti-PcrV, followed by Alex Fluor 594–labeled goat anti–rabbit immunoglobulin. Bar = 10 µm (B).
Quantification of fluorescence positive cells was based on analysis of about 100 cells from three different samples. (C) Wild type PA14 was cultured in the presence of
0.025 µg/ml ciprofloxacin for 2 h and then treated with 0.125 µg/ml ciprofloxacin for 30min. Raw264.7 cells were infected with the surviving bacteria or bacteria
grown in LB at an MOI of 10 for 3.5 h. The anti-PcrV antibody was added to the medium at indicated dilutions. The relative cytotoxicity was determined by the LDH
release assay. Error bars represent the standard errors. (D) Wild type PA14, the 1higA or 1higA1higB mutant was cultured in the presence of 0.025 µg/ml
ciprofloxacin for 2 h and then treated with 0.125 µg/ml ciprofloxacin for 30min. Raw264.7 cells were infected with the survived bacteria or bacteria grown in LB at an
MOI of 10 for 3.5 h. The relative cytotoxicity was determined by the LDH release assay. Error bars represent the standard errors. Each graph represents the results of
three independent experiments. *p < 0.05, ***p < 0.005 by Student’s t-test.
suggesting dispersal of the biofilm (Sun et al., 2014). Therefore, it
might be possible that bacteria inside biofilm are getting exposed
to phagocytes during antibiotic treatment. In this scenario, the
highly dormant persister cells might be protected by the T3SS
proficient cells. It will be interesting to observe the expression
levels of HigB and T3SS genes in individual cells inside biofilm
with or without antibiotic treatment.
Recently, Pu et al. demonstrated that up regulation of drug
eﬄux genes and increased eﬄux activity in persister cells of
E. coli (Pu et al., 2016). Together with our results, these findings
suggest that persister cells might be armed with various defense
and offense factors that enable them to actively defend against
environmental stresses before entering into deeper dormancy
state. Thus, exploration of the gene expression profiles of
persister cells will shed light on their surviving strategies in
various host environments.
MATERIALS AND METHODS
Bacterial Strains and Plasmids
The bacterial strains used in this study are listed in Table S2.
Bacteria were cultured in Luria–Bertani (LB) broth (10 g/l
tryptone, 5 g/l Nacl, 5 g/l yeast extract, pH 7.0–7.5) or LB agar (LB
broth containing 15 g/l agar) under aerobic conditions at 37◦C.
When needed, the medium was supplemented with tetracycline
(100 µg/ml) (BBI life sciences, Shanghai, China), gentamicin
(100 µg/ml) (BBI life sciences), streptomycin (50 µg/ml) (BBI
life sciences), or carbenicillin (150 µg/ml) (BBI life sciences) for
P. aeruginosa, and ampicillin (100 µg/ml) (BBI life sciences) for
E. coli.
Plasmids used in this study are listed in Table S2. For DNA
manipulation, standard protocols or manufacture instructions
of commercial products were followed. Chromosomal gene
mutations were generated as described previously (Hoang et al.,
1998).
Reverse Transcription and Quantitative RT
PCR
Total RNA was isolated from bacteria at indicated time points
with an RNeasy Minikit (Tiangen Biotech, Beijing, China). The
cDNA was synthesized from total RNA using random primers
and PrimeScript Reverse Transcriptase (TaKaRa, Dalian, China).
Specific Primers (Table S2) were used for quantitative RT PCR.
For quantitative RT PCR, cDNA was mixed with 4 pmol of
forward and reverse primers and SYBR Premix Ex TaqTM II
(TaKaRa) in a total reaction volume of 20 µl. The results were
determined using a CFX Connect Real-Time system (Bio-Rad,
USA).
5′ Race Analysis
The transcriptional start site of the higB-higA operon was
determined by 5′ RACE (rapid amplification of cDNA ends).
The cDNA was synthesized from total RNA using primer higA-R
and higB-R. cDNA was purified with a DNA Clean kit (Sangon
Biotech, Shanghai, China) and tailed with poly (dC) using
terminal deoxynucleotidyl transferase (TaKaRa), then amplified
by PCR. The obtained PCR product was ligated into a T-vector
(TaKaRa), then sequenced.
Electrophoretic Mobility Shift Assay
Electrophoretic mobility shift assay (EMSA) was performed as
described with minor modification (Sun et al., 2014). Briefly, a
38-bp DNA fragment corresponding to sequence up-stream of
higB start codon or the 38-bp DNA fragment with palindrome
sequence scrambled as a negative control was synthesized. DNA
fragments (300 ng) were incubated with 0, 4 or 20 nM purified
recombinant HigA protein at 30◦C for 30min in a 20-µl reaction
(10mM Tris-HCl, pH 7.6, 4% glycerol, 1mM EDTA, 5mM
CaCl2, 100mMNaCl, 10mM-β-Mercaptoethanol). Samples were
loaded onto a 8% native polyacrylamide gel in 0.5× Tris-borate-
EDTA (TBE) buffer (0.044 M Tris base, 0.044 M boric acid, 0.001
M EDTA, pH 8.0) that had been prerun for 1 h, electrophoresed
on ice at 90 V for 2 h followed by DNA staining in 0.5 × TBE
containing 0.5 µg/ml ethidium bromide. Bands were visualized
with a molecular imager ChemiDocTM XRS+ (Bio-Rad).
Antitoxin Stabilization Assays
Overnight culture of wild type PA14, a clpP::Tn or lon::Tnmutant
harboring pMMB67EH-higA-His plasmid was sub-cultured in
fresh LB broth to an OD600 of 0.5, then induced with 1 mM
IPTG for 1 h, followed by treatment with 50 µg/ml streptomycin.
Bacteria were collected at 0, 0.5, 1, 2, 3, 4, and 5 h, boiled in 1 ×
SDS loading buffer, then subjected to SDS-PAGE. Proteins was
transferred onto a PVDF membrane and incubated with mouse
anti-His antibody (1:2000) (Millipore, USA) at room temperature
for 1 h. After washing with 1 × phosphate buffered saline (1
× PBS: 274mM NaCl, 5.4mM KCl, 20mM Na2HPO4, 4mM
KH2PO4, pH 7.4) for four times, the membranes were incubated
with a horseradish peroxidase-conjugated goat anti-mouse IgG
(1:2000) (Promega, USA) at room temperature for 1 h. Signals
were detected with the ECL-plus kit (Millipore) and visualized
with a Bio-Rad molecular imager ChemiDocTM XRS+.
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Persistence Assay
Persistence of P. aeruginosa was measured by time-dependent
killing experiments (Dörr et al., 2010). To test the persistence
level induced by sublethal level of ciprofloxacin, overnight
bacterial culture was sub-cultured in fresh LB broth and grown to
an OD600 of 0.4 with or without 0.025 µg/ml ciprofloxacin. Then
the bacterial cultures were exposed to 0.25 µg/ml ciprofloxacin.
To test the effect of higA mutation or higB overexpression on
persister formation, indicated strains were grown to an OD600
of 0.4, followed by treatment with 0.25 µg/ml ciprofloxacin. At
indicated time points, the live bacterial number was determined
by serial dilution and plating. The plate was incubated at 37◦C for
24 h before colony counting.
RNA Sequencing and Data Analysis
PA14 and the higA::Tn mutant were cultured in LB broth
at 37◦C and harvested at log phage (OD600 of 0.8–1.0) and
stationary phase (OD600 of 2.5–3.0). Total RNA was extracted
with an RNeasy Protect Bacteria Mini Kit with on-column
DNase I digestion (Qiagen, Shanghai, China). A Turbo DNA-
free vigorous protocol was used for a second round of DNase
treatment (Ambion). 16S, 23S, and 5S rRNA were removed using
the Ribo-Zero Magnetic Kit (Bacteria) (Epicentre).
Gene expression analysis was conducted via Illumina RNA
sequencing (RNA-Seq technology). RNA-Seq was conducted
for 3 biological replicates of each sample. The rRNA-depleted
RNA was fragmented to 150–200 bp in sizes, then first and
second strand cDNA were synthesized, followed by end repair
and adapter ligation. After 12 cycles of PCR enrichment, the
quality of the libraries was assessed using a Bioanalyzer (Agilent
Technologies). The libraries were sequenced using an Illumina
HiSeq 2500 platform with a paired-end protocol and read lengths
of 100-nt.
The sequencing data was analyzed using themethod described
previously (Chua et al., 2014). Sequence reads were mapped onto
PA14 reference genome (NC_008463) using a CLC genomics
Workbench 8.0 (CLC Bio-Qiagen, Aarhus, Denmark). The count
data of expression values were then analyzed using a DESeq
package of R/Bioconductor. The differentially expressed genes
were identified by performing a negative binomial test using the
DESeq, with the cut-off of fold-change larger than 2. The raw
sequence reads were normalized by dividing with size factors,
then Log2 (N+ 1) transformed.
Immunofluorescence Assay
Bacteria with or without ciprofloxacin treatment were
cytocentrifuged onto glass slides and fixed with 4%
paraformaldehyde at room temperature for 30 min. Then
bacteria were washedwith 1× PBS three times and permeabilized
with 0.2% Triton X-100 in 1 × PBS at room temperature for
5min. After washed twice with PBS, the bacteria were incubated
with rabbit anti-PcrV serum (1:50) in PBSG (1× PBS containing
0.1% gelatin) at 37◦C for 1 h. The cells were washed twice with
PBSG and incubated with the secondary antibody, green or
red-conjugated goat anti- rabbit IgG (1:100) (Thermo Fisher
Scientific, USA) in PBSG at 37◦C for 1 h. To determine the
viability, bacteria were stained with 1 µg/ml PI in 1 × PBS
at room temperature for 15 min after 0.5 or 6 h ciprofloxacin
treatment. Then cells were analyzed by a BX53 fluorescence
microscope (Olympus, Japan).
Cell Culture and Cytotoxicity Assays
Raw264.7 cells and HeLa cells were cultured in DMEM medium
with 10% fetal bovine serum (FBS) at 37◦C in 5% CO2, and
95% air, supplemented with 1% penicillin/streptomycin and
ciprofloxacin (10 µg/ml). Overnight bacterial culture was sub-
cultured in fresh LB broth to OD600 of 0.8 before infection.
Bacteria were washed once and resuspended in 1 × PBS.
Raw264.7 and HeLa cells were infected with bacteria at a
multiplicity of infection (MOI) of 10 or 40, respectively, in
DMEM medium without FBS and antibiotics. At the end
of incubation, lactate dehydrogenase (LDH) present in the
supernatant was measured using the LDH cytotoxicity assay
kit (Beyotime, Haimen, China). Cells treated with LDH release
agent C0017-1 were used as a control of total release (100%
LDH release). The background level (0% LDH release) was
determined with DMEMmedium. The percentage of cytotoxicity
was calculated following the manufacturer’s instruction.
Effector Delivery Assay
HeLa cells were infected with strains containing PexoU -exoU-His
at anMOI of 40. 1.5 h post infection, the cells were washed 3 times
with 1× PBS and lysed with 0.25% Trion-X 100. The Cell lysates
were subjected to 10% SDS-PAGE. Proteins were transferred onto
a PVDF membrane. The protein amounts of actin and ExoU
were determined by Western blot analysis using mouse anti-His
antibody or rabbit anti-β actin antibody (1:2000) (Cell Signaling
Technology, USA).
Protective Effect of Anti-PcrV Antibody on
Raw264.7 Cells
Overnight bacterial cultures were sub-cultured in fresh LB broth
to OD600 of 0.4 with 0.025µg/ml ciprofloxacin, then the bacterial
cultures were exposed to 0.125µg/ml ciprofloxacin. Bacteria with
or without ciprofloxacin treatment were washed with 1 × PBS,
then added to 104 Raw264.7 cells in 200 µl culture medium with
various concentrations (0, 1:100, 1:1000) of either normal rabbit
IgG or rabbit anti-PcrV IgG. Each mixture was incubated at 37◦C
for 3.5 h. Cytotoxicity was measured by LDH release assay as
described above.
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Figure S1 | Expression levels of T3SS genes in wild type PA14, a higA::Tn
mutant and a complemented strain. (A) Cleavage of HigA by the Lon
protease. Wild type PA14, the clpP::Tn and lon::Tn mutants carrying
pMMB67EH-higA-His were cultured in the presence of 1 mM IPTG for 1 h. Then
50 µg/ml spectinomycin was added to the medium. At indicated time points, the
HigA-His levels were determined by Western blot analysis with an anti-His
antibody. Density of each band was quantified with Image J. This graph
represents the results of three independent experiments.(B) Relative mRNA levels
of exsC, exsA, pcrV and exoU in indicated strains at stationary growth phase
(OD600 = 2.5∼3.0). Data represents the mean ± standard deviation from three
independent experiments performed in triplicates. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p <
0.005 compared to wild type PA14 by Student’s t-test. (C) Fluorescence
microscopy of PA14 and the higA::Tn mutant containing PhigB-mcherry. Bacteria
were grown in LB to an OD600 of 3.0, collected and washed with PBS twice. The
bacteria were fixed, permeabilized and then stained with rabbit anti-PcrV followed
by Alex Fluor 594–labeled goat anti–rabbit immunoglobulin. Bar = 20 µm. (D)
Bacteria carrying an exoU-His driven by its native promoter (PexoU-exoU-His)
were grown in LB at 37◦C. At stationary growth phase, bacteria were collected.
Samples from equivalent bacterial cells were loaded into SDS-PAGE gels and
stained with Coomassie blue or probed with an anti-His antibody. (E) HeLa cells
were infected with indicated strains at an MOI of 40 for 3 h, followed by the LDH
release assay. The values and bars represent the means and standard deviations
of triplicate measurements. ∗p < 0.05 by Student’s t-test. HeLa cells were
infected with strains containing PexoU-exoU-His (F) or Plac-gfp-His (G) at an MOI
of 40. 1.5 h after infection, the cells were washed 3 times with PBS and lysed with
0.25% Trion-X 100. The intracellular levels of ExoU-His and GFP-His were
determined by Western blot analysis.
Figure S2 | HigB promotes expression levels of T3SS genes and
cytotoxicity. (A) Relative mRNA levels of T3SS genes in wild type PA14, the
higA::Tn and 1higB1higA mutants. Bacteria were grown to an OD600 of 1.0,
followed by total RNA isolation. The mRNA levels of exsC, exsA, pcrV, and exoU
were determined by quantitative RT-PCR. (B) Raw264.7 cell cells were infected
with indicated strains at an MOI of 10 for 3.5 h. The relative cytotoxicity was
determined by the LDH release assay. (C) PA14 or the exsA::Tn mutant containing
pMMB67EH-higB-His or pMMB67EH was grown in the presence of indicated
concentrations of IPTG for 3 h. The levels of HigB in bacterial cell lysates were
determined by Western blot analysis. The loading control was displayed in
Figure 4E. The relative density of each band was determined by Image J. (D)
HeLa cells were infected with the indicated bacteria at an MOI of 40 for 3 h,
followed by LDH release assay. ND, not detectable. The values and bars represent
the means and standard deviations of triplicate measurements. ∗p < 0.05, ∗∗p <
0.01, ∗∗∗p < 0.005 by Student’s t-test.
Figure S3 | Fluorescence microscopy of PA14 containing PhigB-gfp. At an
OD600 of 0.3, bacteria were incubated with 0.025 µg/ml ciprofloxacin for 2 h and
then treated with 0.25 µg/ml ciprofloxacin for 6 h in LB. The ciprofloxacin treated
and untreated bacteria were collected and washed with PBS twice. The bacterial
cells were stained with PI (A) or immunostained with rabbit anti-PcrV followed by
Alex Fluor 594–labeled goat anti–rabbit immunoglobulin. Bar = 10 µm (B).
Quantification of fluorescence positive cells was based on analysis of about 100
cells from three different samples. (C) PA14 or the exsA::Tn mutant were cultured
in the presence or absence of 0.025 µg/ml ciprofloxacin for 2 h and then treated
with 0.125 µg/ml ciprofloxacin for 30min or 6 h. Or, the PA14 cells were incubated
at 50◦C for 30min. Live bacteria were collected. Raw264.7 cells were infected
with the indicated bacteria at an MOI of 10 for 3.5 h. (D) HeLa cells were infected
with the indicated bacteria at MOI of 40 for 3.0 h. The relative cytotoxicity levels
were determined by LDH release assay. ND, not detectable. ∗p < 0.05, compared
to each of the other samples by Student’s t-test.
Figure S4 | Fluorescence microscopy of 1higB mutant containing
PhigB-gfp. At an OD600 of 0.3, a 1higB mutant containing PhigB-gfp were
incubated with 0.025 µg/ml ciprofloxacin for 2 h and then treated with 0.125
µg/ml ciprofloxacin for 30min in LB. The ciprofloxacin treated and untreated
bacteria were collected and washed with PBS twice. The bacterial cells were
stained with PI (A) or immunostained with rabbit anti-PcrV followed by Alex Fluor
594–labeled goat anti–rabbit immunoglobulin (B). Bar = 10 µm.
Figure S5 | Fluorescence microscopy of 1higB1higA mutant containing
PhigB-gfp. At the OD600 of 0.3, a 1higB1higA mutant containing PhigB-gfp were
incubated with 0.025 µg/ml ciprofloxacin for 2 h and then treated with 0.125
µg/ml ciprofloxacin for 30min in LB. The ciprofloxacin treated and untreated
bacteria were collected and washed with PBS twice. The bacterial cells were
stained with PI (A) or immunostained with rabbit anti-PcrV followed by Alex Fluor
594–labeled goat anti–rabbit immunoglobulin (B). Bar = 10 µm.
Table S1 | PA14 Transcriptome analysis: differentially regulated genes.
Table S2 | Bacterial strains, plasmids and primers used in this study.
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